Rodríguez-Padilla Á, Morales-Martín G, Pérez-Quintero R, et al. Diversion colitis: macro and microscopic findings after probiotics stimulation [J]. Biology(Basel), 2021, 10(4): 303.
[3]
Bajic D, Niemann A, Hillmer A K, et al. Gut microbiota-derived propionate regulates the expression of reg3 mucosal lectins and ameliorates experimental colitis in mice[J]. J Crohns Colitis, 2020, 14(10): 1462-1472.
[4]
Rodríguez-Padilla Á, Morales-Martín G, Pérez-Quintero R, et al. Serological biomarkers and diversion colitis:changes after stimulation with probiotics[J]. Biomolecules, 2021, 11(5): 684.
[5]
Velázquez O C, Lederer H M, Rombeau J L. Butyrate and the colonocyte. Production, absorption, metabolism and therapeutic implications[J]. Adv Exp Med Biol, 1997, 427: 123-134.
[6]
Ferguson C M, Siegel R J. A prospective evaluation of diversion colitis[J]. Am Surg, 1991, 57(1): 46-49.
[7]
Komorowski R A. Histologic spectrum of diversion colitis[J]. Am J Surg Pathol,1990,14(6):548-554.
[8]
Zhang W, Zou G, Li B, et al. Fecal microbiota transplantation (FMT) alleviates experimental colitis in mice by gut microbiota regulation[J]. J Microbiol Biotechnol, 2020, 30(8): 1132-1141.
[9]
Szczepkowski M, Banasiewicz T, Kobus A. Diversion colitis 25 years later: thephenome-none of the disease[J]. Int Colorectal Dis, 2017, 32(8): 1191-1196.
[10]
Burman J H, Thompson H, Cooke W T, et al. The effects of diversion of intestinal contents on the progress of Crohn's disease of the large bowel[J]. Gut, 1971, 12(1): 11-15.
[11]
Son D N, Choi D J, Woo S U, et al. Relationship between diversion colitis and quality of life in rectal cancer[J]. World Gastroenterol, 2013, 19(4): 542-549.
[12]
Lane A, Dalkie N, Henderson L, et al. An elemental diet is effective in the management of diversion colitis[J]. Gastroenterol Hepatol BedBench, 2021, 14(1): 81-84.
[13]
Donahue C A, Chaudhry V, Mantilla N. Autologous fecal transplant for the treatment of microcolon due to diversion colitis[J]. Tech Coloproctol, 2022, 26(1): 79-81.
[14]
Le Berre C, Roda G, Nedeljkovic P M, et al. Modernuse of 5-aminosalicylic acid compounds for ulcerative colitis[J]. Expert Opin BiolTher, 2020, 20(4): 363-378.
[15]
Triantafillidis J K, Nicolakis D, Mountaneas G, et al. Treatment of diversion colitis with 5-aminosalicylic acid enemas: comparison with betamethasone enemas[J]. Am Gastroenterol, 1991, 86(10):1552-1553.
[16]
Tripodi J, Gorcey S, Burakoff R. A case of diversion colitis treated with 5-aminosalicylic acid enemas[J]. Am Gastroenterol, 1992, 87(5): 645-647.
[17]
Caltabiano C, Máximo F R, Spadari A P, et al. 5-aminosalicylic acid (5-ASA) can reduce levels of oxidative DNA damage in cells of colonic mucosa with and without fecal stream[J]. Dig Dis Sci, 2011, 56(4):1037-1046.
[18]
Delben A G, Martinez C A R, Sato D T, et al. Evaluation of the effects of biological therapy with infliximab in an experimental model of diversion colitis[J]. Gastrointest Surg, 2021, 25(10): 2681- 2683.
[19]
Luceri C, Femia A P, Fazi M, et al. Effect of buty rate enemas on gene expression profiles and endoscopic/histopathological scores of diverted colorectal mucosa: a randomized trial [J]. Dig Liver Dis, 2016,48(1): 27-33.
[20]
Boyce S A, Hendry W S. Diversion colitis presenting with massive rectal distension and bilateral ureteric obstruction[J]. Int Colorectal Dis, 2008, 23(11): 1143-1144.
[21]
Kim Y, Hwang S W, Kim S, et al. Dietary cellulose prevents gut inflammation by modulating lipid metabolism and gut microbiota[J]. Gut Microbes, 2020,11(4): 944-961.
[22]
de Oliveira-Neto J P,de Aguilar-Nascimento J E. Intraluminal irrigation with fibers improves mucosal inflammation and atrophy in diversion colitis[J]. Nutrition, 2004, 20(2):197-199.
Martinez C A, Almeida M G, Silva C M, et al. Enemas with N-acetylcysteine can reduce the level of oxidative damage in cells of the colonic mucosa diverted from the faecal stream[J]. Dig Dis Sci,2013, 58(12): 3452-3459.
Nyabanga C T, Shen B. Endoscopic treatment of bleeding diversion pouchitiswith high-concentration dextrose spray[J]. ACG Case Rep, 2017, 29(4): 51.
[31]
Szczepkowski M, Banasiewicz T, Kobus A. Diversion colitis 25 years later: the phenomenon of the disease[J]. Int J Colorectal Dis, 2017, 32(8):1191-1196.
[32]
Ma C K, Gottlieb C, Haas P A. Diversion colitis: a clinic pathologic study of 21 cases[J]. Hum Pathol, 1990, 21(4): 429-436.
[33]
Gundling F, Tiller M, Agha A, et al. Successful autologous fecal transplantation for chronic diversion colitis[J]. Tech Coloproctol, 2015,19(1): 51-52.
[34]
Watanabe C, Hokari R, Miura S. Chronic antibiotic-refractory diversion paucities successfully treated with leukocyte apheresis[J]. Ther Apher Dial, 2014,18(6): 644-645.
2022, Vol. 33 
